Health and Family Welfare Minister Mansukh Mandaviya said on Tuesday that the monthly production capacity of the anti-Kovid-19 vaccine Kovishield is expected to increase from 11 crore doses per month to about 12 crore and the production capacity of Covaccine from 25 crore doses per month to about 58 million. Mandaviya gave this information to the Rajya Sabha in a written reply to a question.
He said that Covishield Serum is prepared by Institute, Pune while Covaccine is developed by Bharat Biotech International Ltd. Made by Hyderabad. He said that as per the information given by the manufacturers, the monthly production capacity of Kovishield vaccine is expected to increase from 11 crore doses per month to more than 12 crores, while the production capacity of Covaccine is expected to increase from 2.5 crore doses per month to about 58 crores per month Is.
Also Mandaviya said, 'In addition, the Department of Biotechnology under the Ministry of Science and Technology has started 'Mission Kovid Suraksha-Indian Kovid-19 Vaccine Development Mission'. The mission is being implemented by the Biotechnology Industrial Research Assistance Council, a Public Sector Undertaking (PSU) of the Department of Biotechnology.
Under this mission, Bharat Biotech and Haffkine Biopharmaceutical Corporation Ltd., Mumbai for production of vaccine; Indian Immunologicals Ltd. (IIL), Hyderabad and Bharat Immunologicals Biologicals Ltd. (Bibcol), Bulandshahr has been given assistance. He said that the Government of India has simplified and streamlined the regulatory norms for approval of vaccines.
No comments:
Post a Comment